BioMimetic Therapeutics, Inc. to Present at the INVEST Tennessee Equity Conference FRANKLIN, Tenn., May 25, 2010 (GLOBE NEWSWIRE) -- BioMimetic Therapeutics, Inc. (Nasdaq:BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate...